Viracta Therapeutics Stock Quote VIRX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.5283

Bid

0.5169

Ask

0.5284

Volume

15,520,754

0.00 Day's Range 0.00

0.4147 52 Week Range 1.5151

Market Cap

20.748M

Previous Close

0.46515

Open

Last Trade

0.5184

Last Trade Time

09:09:17

Financial Volume

VWAP

Average Volume (3m)

113,885

Shares Outstanding

39,272,434

Dividend Yield

PE Ratio

-0.36

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.47. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.4147 to $ 1.5151.

Viracta Therapeutics currently has 39,272,434 shares outstanding. The market capitalization of Viracta Therapeutics is $18.27 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.36.

Venue Change

Mon, Nov 18, 2013 12:00 - Capital Group Holdings, Inc. (CGHC: OTC Link) - Venue Change - The symbol, CGHC, no longer trades on OTC Link/FINRA BB. As of Mon, Nov 18, 2013, CGHC trades on OTC Link...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0483	10.0625	0.48	0.507	0.4147	193580	0.45418147	CS
4	-0.0507	-8.75647668394	0.579	0.58	0.4147	114636	0.4781239	CS
12	-0.2817	-34.7777777778	0.81	0.846	0.4147	113885	0.53797602	CS
26	-0.1141	-17.7615193026	0.6424	1.31	0.4147	109799	0.73048854	CS
52	-0.8917	-62.7957746479	1.42	1.5151	0.4147	116874	0.70442409	CS
156	-9.7417	-94.8558909445	10.27	10.27	0.4147	165987	2.75816881	CS
260	-16.2317	-96.8478520286	16.76	18.24	0.4147	190190	4.68180922	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALBTAvalon GloboCare Corporation	$ 0.9146 (258.67%)	70.46M
DGLYDigital Ally Inc	$ 1.49 (75.31%)	22.41M
SGDSafe and Green Development Corporation	$ 0.365 (55.39%)	1.73M
SERVServe Robotics Inc	$ 13.90 (34.04%)	5.43M
CDTConduit Pharmaceuticals Inc	$ 0.184 (33.82%)	44.88M
TCBPTC BioPharm Holdings PLC	$ 2.15 (-41.10%)	38.47k
HNNAHennessy Advisors Inc	$ 7.02 (-36.56%)	27.1k
SYTASiyata Mobile Inc	$ 2.0108 (-28.95%)	47.27k
VEVVicinity Motor Corporation	$ 0.1511 (-27.63%)	4.24M
SURGSurgePays Inc	$ 2.11 (-22.43%)	111.22k
ALBTAvalon GloboCare Corporation	$ 0.9146 (258.67%)	70.46M
CDTConduit Pharmaceuticals Inc	$ 0.184 (33.82%)	44.88M
DGLYDigital Ally Inc	$ 1.49 (75.31%)	22.41M
EJHE Home Household Service Holdings Ltd	$ 0.1584 (5.60%)	18.88M
NVDANVIDIA Corporation	$ 118.64 (2.15%)	16.17M